PDLIM7 and neoplasm: A recent study showed that LMP1 signaling in B cells led to an overexpression of tumour associated antigens presented on MHC-I and II, and the upregulation of costimulatory ligands CD70 and OX40L, thereby inducing potent cytotoxic CD4+ and CD8+ T-cell responses (193).